-+ 0.00%
-+ 0.00%
-+ 0.00%

AdJane Unveils Mucosal Booster Strategy for Next-Generation Respiratory Vaccine Franchises

Barchart·09/10/2026 02:05:00
Listen to the news

White Paper shows how AdJane's clinically validated Nm-nOMV platform could add a proprietary mucosal component to existing intramuscular vaccination programs

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.